[Usefulness of endothelin-1 determinations in the diagnosis of cardiovascular diseases]

Rafał Celiński1

  • 1Uniwersytet Rzeszowski, Instytut Fizjoterapii.

Insights

Endothelin-1 (ET-1) is implicated in cardiovascular diseases like coronary heart disease. Elevated ET-1 levels are observed in conditions such as heart failure and myocardial infarction, but its diagnostic specificity requires further investigation.

Area of Science:

  • Vascular biology and cardiovascular pathophysiology.
  • Endothelial function and hemostasis research.

Context:

  • The endothelium plays a crucial role in cardiovascular disease pathogenesis, particularly coronary heart disease.
  • Vascular hemostasis relies on the balance between endothelial vasoconstrictive and vasodilatory substances.
  • Endothelin-1 (ET-1) is a primary vasoconstrictive substance impacting vascular tone.

Purpose:

  • To investigate the diagnostic significance of endothelin-1 (ET-1) levels in cardiovascular diseases.
  • To assess the role of ET-1 in the diagnosis of coronary heart disease and related conditions.

Summary:

  • Numerous studies indicate elevated serum ET-1 concentrations in patients with ischemic heart disease, especially unstable forms.
  • High ET-1 levels are frequently observed in patients experiencing myocardial infarction.
  • Markedly increased ET-1 blood levels correlate with the NYHA functional class in patients with heart failure.

Impact:

  • High ET-1 concentrations are present across various disease entities, suggesting limited diagnostic specificity.
  • Further research is necessary to elucidate the precise diagnostic utility of ET-1 in cardiovascular diseases.
  • Understanding ET-1's role may lead to improved diagnostic markers for cardiovascular conditions.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...